Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.905
Filtrar
1.
Proc Natl Acad Sci U S A ; 119(32): e2206000119, 2022 08 09.
Artículo en Inglés | MEDLINE | ID: mdl-35914132

RESUMEN

Estrogen and progesterone specify the establishment of uterine receptivity mainly through their respective nuclear receptors, ER and PR. PR is transcriptionally induced by estrogen-ER signaling in the endometrium, but how the protein homeostasis of PR in the endometrium is regulated remains elusive. Here, we demonstrated that the uterine-selective depletion of P38α derails normal uterine receptivity ascribed to the dramatic down-regulation of PR protein and disordered progesterone responsiveness in the uterine stromal compartment, leading to defective implantation and female infertility. Specifically, Ube3c, an HECT family E3 ubiquitin ligase, targets PR for polyubiquitination and thus proteasome degradation in the absence of P38α. Moreover, we discovered that P38α restrains the polyubiquitination activity of Ube3c toward PR by phosphorylating the Ube3c at serine741 . In summary, we provided genetic evidence for the regulation of PR protein stability in the endometrium by P38α and identified Ube3c, whose activity was modulated by P38α-mediated phosphorylation, as an E3 ubiquitin ligase for PR in the uterus.


Asunto(s)
Implantación del Embrión , Sistema de Señalización de MAP Quinasas , Proteína Quinasa 14 Activada por Mitógenos , Progesterona , Útero , Animales , Implantación del Embrión/fisiología , Endometrio/metabolismo , Femenino , Infertilidad Femenina , Proteína Quinasa 14 Activada por Mitógenos/metabolismo , Fosforilación , Progesterona/metabolismo , Receptores de Progesterona/metabolismo , Ubiquitina-Proteína Ligasas/genética , Ubiquitina-Proteína Ligasas/metabolismo , Ubiquitinación , Útero/enzimología , Útero/metabolismo
2.
Am J Physiol Regul Integr Comp Physiol ; 321(6): R833-R843, 2021 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-34668428

RESUMEN

Angiotensin-converting enzyme 2 (ACE2) is a membrane-bound protein containing 805 amino acids. ACE2 shows approximately 42% sequence similarity to somatic ACE but has different biochemical activities. The key role of ACE2 is to catalyze the vasoconstrictor peptide angiotensin (ANG) II to Ang-(1-7), thus regulating the two major counterbalancing pathways of the renin-angiotensin system (RAS). In this way, ACE2 plays a protective role in end-organ damage by protecting tissues from the proinflammatory actions of ANG II. The circulating RAS is activated in normal pregnancy and is essential for maintaining fluid and electrolyte homeostasis and blood pressure. Renin-angiotensin systems are also found in the conceptus. In this review, we summarize the current knowledge on the regulation and function of circulating and uteroplacental ACE2 in uncomplicated and complicated pregnancies, including those affected by preeclampsia and fetal growth restriction. Since ACE2 is the receptor for SARS-CoV-2, and COVID-19 in pregnancy is associated with more severe disease and increased risk of abnormal pregnancy outcomes, we also discuss the role of ACE2 in mediating some of these adverse consequences. We propose that dysregulation of ACE2 plays a critical role in the development of preeclampsia, fetal growth restriction, and COVID-19-associated pregnancy pathologies and suggest that human recombinant soluble ACE2 could be a novel therapeutic to treat and/or prevent these pregnancy complications.


Asunto(s)
Enzima Convertidora de Angiotensina 2/metabolismo , Placenta/enzimología , Complicaciones del Embarazo/enzimología , Sistema Renina-Angiotensina , Útero/enzimología , Enzima Convertidora de Angiotensina 2/uso terapéutico , Animales , Presión Sanguínea , COVID-19/enzimología , COVID-19/fisiopatología , COVID-19/virología , Femenino , Retardo del Crecimiento Fetal/enzimología , Retardo del Crecimiento Fetal/fisiopatología , Humanos , Mediadores de Inflamación/metabolismo , Placenta/fisiopatología , Preeclampsia/enzimología , Preeclampsia/fisiopatología , Embarazo , Complicaciones del Embarazo/tratamiento farmacológico , Complicaciones del Embarazo/fisiopatología , Complicaciones Infecciosas del Embarazo/enzimología , Complicaciones Infecciosas del Embarazo/fisiopatología , Complicaciones Infecciosas del Embarazo/virología , SARS-CoV-2/patogenicidad , Útero/fisiopatología , Equilibrio Hidroelectrolítico
3.
Biochem Pharmacol ; 193: 114790, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34600915

RESUMEN

Preeclampsia is a pregnancy-related disorder of maternal hypertension-in-pregnancy (HTN-Preg) and often fetal growth restriction (FGR). Placental ischemia could be an initiating event leading to inadequate vascular and uteroplacental remodeling and HTN-Preg; however, the molecular targets are unclear. To test the hypothesis that placental ischemia-induced release of proinflammatory cytokines target vascular and uteroplacental matrix metalloproteinases (MMPs), we tested if infusing TNFα (200 ng/kg/day) in day-14 pregnant (Preg) rats causes MMP imbalance and collagen accumulation, and if infusing TNFα decoy receptor Etanercept (0.4 mg/kg/day) in HTN-Preg rats with reduced uteroplacental perfusion pressure (RUPP) reverses MMP imbalance and collagen accumulation. On gestational day-19, blood pressure (BP) was higher in Preg + TNFα and RUPP vs Preg rats, and restored in RUPP + Etanercept rats. Gelatin zymography and Western blots revealed decreases in MMP-2 and MMP-9 and increases in MMP-1 and MMP-7 in aorta, uterus and placenta of Preg + TNFα and RUPP, that were reversed in RUPP + Etanercept rats. Collagen-I and IV were abundant in Preg + TNFα and RUPP, and were decreased in RUPP + Etanercept rats. The litter size, uterine, placenta, and pup weight were markedly reduced in RUPP, insignificantly reduced in Preg + TNFα, and slightly improved in RUPP + Etanercept rats. Thus TNFα blockade reverses the decreases in vascular and uteroplacental MMP-2 and MMP-9, and the increases in MMP-1, MMP-7 and accumulation of collagen-I and IV induced by placental ischemia and TNFα in HTN-Preg rats. Targeting TNFα using cytokine antagonists, or MMPs using MMP modulators could rectify MMP imbalance and collagen accumulation, restore vascular and uteroplacental remodeling, and improve BP in HTN-Preg and preeclampsia.


Asunto(s)
Etanercept/farmacología , Metaloproteinasas de la Matriz/metabolismo , Placenta/enzimología , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Útero/enzimología , Animales , Femenino , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Hipertensión , Tamaño de la Camada , Metaloproteinasas de la Matriz/genética , Circulación Placentaria , Embarazo , Ratas , Ratas Sprague-Dawley , Factor de Necrosis Tumoral alfa/farmacología
4.
Int J Mol Sci ; 22(10)2021 May 13.
Artículo en Inglés | MEDLINE | ID: mdl-34068371

RESUMEN

This study aimed to describe glutathione peroxidase 4 (GPx4) in rat oocytes, preimplantation embryos, and female genital organs. After copulation, Sprague Dawley female rats were euthanized with anesthetic on the first (D1), third (D3), and fifth days of pregnancy (D5). Ovaries, oviducts, and uterine horns were removed, and oocytes and preimplantation embryos were obtained. Immunohistochemical, immunofluorescent, and Western blot methods were employed. Using immunofluorescence, we detected GPx4 in both the oocytes and preimplantation embryos. Whereas in the oocytes, GPx4 was homogeneously diffused, in the blastomeres, granules were formed, and in the blastocysts, even clusters were present mainly around the cell nuclei. Employing immunohistochemistry, we detected GPx4 inside the ovary in the corpus luteum, stroma, follicles, and blood vessels. In the oviduct, the enzyme was present in the epithelium, stroma, blood vessels, and smooth muscles. In the uterus, GPx4 was found in the endometrium, myometrium, blood vessels, and stroma. Moreover, we observed GPx4 positive granules in the uterine gland epithelium on D1 and D3 and cytoplasm of fibroblasts forming in the decidua on D5. Western blot showed the highest GPx4 levels in the uterus and the lowest levels in the ovary. Our results show that the GPx4 is necessary as early as in the preimplantation development of a new individual because we detected it in an unfertilized oocyte in a blastocyst and not only after implantation, as was previously thought.


Asunto(s)
Blastocisto/enzimología , Implantación del Embrión , Desarrollo Embrionario , Regulación del Desarrollo de la Expresión Génica , Regulación Enzimológica de la Expresión Génica , Oocitos/enzimología , Fosfolípido Hidroperóxido Glutatión Peroxidasa/metabolismo , Animales , Blastocisto/citología , Endometrio/enzimología , Femenino , Masculino , Oocitos/citología , Ovario/enzimología , Fosfolípido Hidroperóxido Glutatión Peroxidasa/genética , Embarazo , Ratas , Ratas Sprague-Dawley , Útero/enzimología
5.
Biotech Histochem ; 96(5): 331-338, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32654526

RESUMEN

Diabetes mellitus (DM) is a common metabolic disorder with complications including nephropathy, cardiomyopathy, neuropathy and infertility. We investigated nitric oxide synthase (NOS) expression in uterine tissue of diabetic rats. The rats were assigned randomly to four groups of ten: group C, control; group 1, diabetic for 1 month; group 2, diabetic for 2 months; group 3, diabetic for 3 months. DM was induced by streptozotocin injection. nNOS, iNOS, eNOS expressions and TUNEL staining were assessed in uterine tissue and luteinizing hormone (LH), follicle stimulating hormone (FSH) and estrogen were measured in blood samples. The uterine epithelium, connective tissue of the endometrium, myometrium wall thickness and number of apoptotic cells were decreased in groups 1 - 3 compared to group C. nNOS and eNOS expression was increased in diabetic groups, but iNOS expression was similar to group 1. FSH was increased in group 2, but serum LH and estrogen levels were unchanged among groups. DM damages uterine tissue, and NOS, especially nNOS and eNOS, contributes to this damage.


Asunto(s)
Útero/enzimología , Animales , Diabetes Mellitus Experimental , Femenino , Óxido Nítrico , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo I , Óxido Nítrico Sintasa de Tipo II/metabolismo , Óxido Nítrico Sintasa de Tipo III/metabolismo , Ratas , Estreptozocina
6.
Histol Histopathol ; 35(11): 1337-1351, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32940340

RESUMEN

mTOR is a member of the PI3K/Akt/mTOR signaling pathway that participates in cell growth, proliferation, protein synthesis, transcription, angiogenesis, apoptosis and autophagy. mTOR and MAPK pahways are two important key signal pathways which are related to each other. We investigated the role of mTOR and other signaling molecules in rat ovaries and uteruses in stages of the estrous cycle. Young adult female rats were divided into four groups as proestrous, estrous, metestrous and diestrous according to vaginal smears. Immunohistochemical staining of mTORC1, IGF1, PI3K, pAKT1/2/3, ERK1 and pERK1/2 was performed and pAKT1/2/3 and ERK1 were also analyzed using western blotting on ovarian and uterine tissue samples. According to our results, PI3K/Akt/mTOR and ERK/pERK showed an increase in the rat ovulation period. When all the groups were evaluated the immunoreactivities for all of the antibodies were detected in the oocytes, granulosa and theca cells, corpus luteum and stroma of ovary and lamina propria, surface and glandular epithelium of uterus with the strongest observed with anti-ERK1 antibody and then with a decreasing trend with anti-mTORC1, anti-pAkt1/2/3, anti-IGF1, anti-PI3K and anti-pERK1/2 antibodies in the proestrus and estrus stages. Differently from other parts of the ovary, highest antibody expression in the corpus luteum was observed in the metestrous stage. Moreover, the existence of pAKT1/2/3 and ERK1 proteins was confirmed with the Western blotting technique. We suggest that mTOR and mTOR-related ERK signaling molecules may participate in the rat ovulation process.


Asunto(s)
Ciclo Estral/metabolismo , Ovario/enzimología , Serina-Treonina Quinasas TOR/metabolismo , Útero/enzimología , Animales , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Femenino , Inmunohistoquímica , Factor I del Crecimiento Similar a la Insulina/metabolismo , Diana Mecanicista del Complejo 1 de la Rapamicina/metabolismo , Fosfatidilinositol 3-Quinasa/metabolismo , Fosforilación , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ratas Wistar , Transducción de Señal
7.
Exp Biol Med (Maywood) ; 245(16): 1490-1503, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32746633

RESUMEN

IMPACT STATEMENT: Infertility resulting from reproductive impairment is traumatic in families. Exposure to chemicals may play insidious roles not easily connected to infertility. We examined benzo[a]pyrene (BaP), and N-methyl nitrosourea (NMU)-induced ovarian and uterine toxicity and the role of Calliandra portoricensis in mitigating toxicity. In a bid to illuminate folk medical claims cloaked in mystery, unearthing lost knowledge, advance natural chemopreventive agents, and report new evidence lacking in the literature attributed to CP. Although CP is known to exhibit anticonvulsant, antidiarrheal, antipyretic, antirheumatic, and analgesic effects in humans, its possible roles for mitigating toxicity stemming from inadvertent chemical exposures are reported here. Our findings affirm and further show that CP abates toxic response incumbent on oxidative damage and inflammatory responses associated with NMU and BaP exposure. Development of phytochemical derived from CP may serve as a potential natural therapy against chemical toxicities in individuals inadvertently exposed, and promote human health and reproductive satiety.


Asunto(s)
Benzo(a)pireno/toxicidad , Fabaceae/química , Inflamación/patología , Metilnitrosourea/toxicidad , Ovario/patología , Útero/patología , Animales , Biomarcadores/metabolismo , Peso Corporal/efectos de los fármacos , Femenino , Hormonas/metabolismo , Tamaño de los Órganos/efectos de los fármacos , Ovario/efectos de los fármacos , Ovario/enzimología , Oxidación-Reducción , Extractos Vegetales/farmacología , Ratas Sprague-Dawley , Útero/efectos de los fármacos , Útero/enzimología , Vincristina/farmacología , Proteína X Asociada a bcl-2/metabolismo
8.
Open Vet J ; 10(2): 157-163, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32821660

RESUMEN

Background: In several mammals, subfertility or infertility associated with endometritis was reported. Although there have been studies about endometritis in bitches, the pathophysiological mechanisms are not completely known. Aim: This study aimed to evaluate the immunohistochemical expression of Cyclooxygenase 2 (COX2) in clinically healthy bitches with normal uterine tissue and bitches with endometritis. Methods: Forty-eight mixed breed bitches in diestrus were used. Uterine biopsies were collected for diagnosis [normal endometrium (n = 15; NE), cystic endometrial hyperplasia (n = 1), atrophy (n= 2), acute endometritis (n = 9; AE), subacute endometritis (n = 7; SE), and chronic endometritis (n = 14; CE)]. Immunostaining and quantification of positively stained cells was performed on full-thickness uterine biopsies. Data were analyzed by the GLIMMIX procedure of SAS. Results: COX2 immunostaining was scattered and restricted to cells in the stroma in bitches with NE. However, in bitches with endometritis, strong staining was observed in the luminal epithelium, glandular epithelium, and stromal cells. Staining was also observed in inflammatory cells localized in the stroma as well as inside of the glands. The percentage of COX2 positive stromal cells in bitches with AE, SE, and CE was significantly higher compared with NE (p < 0.005). In addition, the percentage of COX2 positive stromal cells in bitches with SE, and CE was significantly lower compared with AE (p < 0.003). Conclusion: COX2 could be involved in the pathophysiological mechanisms producing endometritis without the presence of cystic endometrial hyperplasia in bitches. However, further researches on this topic are required.


Asunto(s)
Ciclooxigenasa 2/metabolismo , Enfermedades de los Perros/enzimología , Hiperplasia Endometrial/veterinaria , Endometritis/veterinaria , Animales , Diestro , Enfermedades de los Perros/fisiopatología , Perros , Hiperplasia Endometrial/enzimología , Hiperplasia Endometrial/fisiopatología , Endometritis/enzimología , Endometritis/fisiopatología , Femenino , Inmunohistoquímica/veterinaria , Células del Estroma/enzimología , Útero/enzimología , Útero/fisiopatología
9.
Aging (Albany NY) ; 11(21): 9500-9529, 2019 11 10.
Artículo en Inglés | MEDLINE | ID: mdl-31708494

RESUMEN

Researchers have long assumed that systematic estrogen fading might contribute to the sustained progression of menopausal degenerate syndromes, although definitive evidence has not been presented. Whether such findings represent a causal contribution or are the result of opportunistic messengers sent from the reproductive system to the brain is also a vital question. We constructed a multiscale network of the ovariectomy (OVX) induced estrogen receptors depletion (ER-depletion) model and integrated targeted proteomic, targeted lipidomic, cytochemical, and histopathological data across three tissues from the ovariectomy rodent model. We found that compared to control rats, OVX rats showed increased renal and uterine prostaglandin D2 synthase (Ptgds) expression and decreased hypothalamic Ptgds expression, abnormal Ptgds metabolites, the degenerate renal function profiles and decreased cognitive ability (learning and memory) in Morris water maze test. Importantly, we observed a regulatory relationship among ER (particularly ERß), the degree of the pathological phenotype, learning behavior test and the 'hypothalamus-uterus-kidney (HUK) axis functions. Collectively, this study elucidates that ER depletion promoted HUK aging is mostly attributed to a renal ERß/Ptgds signalling imbalance.


Asunto(s)
Oxidorreductasas Intramoleculares/metabolismo , Riñón/metabolismo , Metabolismo de los Lípidos/genética , Lipocalinas/metabolismo , Menopausia/metabolismo , Receptores de Estrógenos/deficiencia , Animales , Eicosanoides/sangre , Eicosanoides/orina , Femenino , Hipotálamo/enzimología , Aprendizaje por Laberinto , Menopausia/genética , Ovariectomía , Proteoma , Ratas Sprague-Dawley , Transducción de Señal , Útero/enzimología
10.
Biochemistry ; 58(38): 3938-3942, 2019 09 24.
Artículo en Inglés | MEDLINE | ID: mdl-31474112

RESUMEN

Metalloproteinases (MMPs) are zinc-dependent endopeptidases that cleave various proteins to regulate normal and diseased cellular functions, and as such, they play significant roles in human tissue development, homeostasis, and the pathogenesis of many diseases, including cancers, endometriosis, arthritis, etc. Most MMPs are produced as zymogenic latent enzymes that must be cleaved to activate their catalytic regions, and localized endogenous protein inhibitors further regulate activity. Accordingly, they operate within recursive networks to degrade extracellular matrix proteins and regulate cell signaling by cleaving growth factors and receptors at the cell surface and in the local pericellular environment. Thus, high-resolution information about the concentrations of specific active MMPs, revealing their intricate regulatory networks, may improve disease diagnosis and treatment. Here, we introduce a new and readily mastered method for measuring MMP activities in a multiplex fashion. We integrate aspects of activity-based enzyme labeling with commercial high-throughput, multiplexed protein quantification to yield the metalloproteinase activity multiplexed bead-based immunoassay (MAMBI). Assays of recombinant active MMP-1, -2, -3, -7, -8, -9, -12, and -13 establish the sensitivity and selectivity of MAMBI detection. Levels of active native MMPs are similarly characterized in conditioned cell culture medium, menstrual effluent, and uterine tissue. In a single MAMBI (5 µL), we achieve sensitivities equal to those from leading single-plex MMP activity detection strategies (e.g., 10-15 M for MMP-1). We also demonstrate high-throughput inhibitor screening via the MAMBI approach in complex, patient-derived samples.


Asunto(s)
Ensayos Analíticos de Alto Rendimiento/métodos , Inmunoensayo/métodos , Metaloproteinasas de la Matriz/análisis , Adulto , Técnicas de Cultivo de Célula , Línea Celular Tumoral , Evaluación Preclínica de Medicamentos/métodos , Femenino , Humanos , Inhibidores de la Metaloproteinasa de la Matriz/farmacología , Metaloproteinasas de la Matriz/metabolismo , Persona de Mediana Edad , Proteínas Recombinantes/análisis , Proteínas Recombinantes/metabolismo , Útero/enzimología
11.
Gen Physiol Biophys ; 38(5): 427-434, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31411575

RESUMEN

The objective of this study is to investigate the effects of nimesulide on ketamine-induced ovarian and uterine toxicity by biochemical and histopathological examinations. Ketamine is an anesthetic agent whose use leads to overproduction of catecholamines. Nimesulide is a cyclooxygenase-2 inhibitor, which has also been reported to exert a significant antioxidant effect. Wistar albino female rats were randomly divided into three groups as follows: ketamine group (60 mg/kg), ketamine (60 mg/kg) + nimesulide (50 mg/kg) group, and a healthy control group. Then, the biochemical levels and histopathological findings in the ovaries and uteri of the rats were examined for malondialdehyde, myeloperoxidase, total glutathione and superoxide dismutase. The study demonstrated that, in the uterine and ovarian tissues of rats that have been administered ketamine, there was a decrease in the levels of total glutathione and superoxide dismutase, while malondialdehyde and myeloperoxidase was increased: however it was observed that these ratios were reversed in the ketamine+nimesulide group. It was also proved that the negative effects of ketamine can be corrected with nimesulide when the myometrial and endometrial thicknesses are compared. Antioxidants such as nimesulide may protect against the damage caused by ketamine to the genital organs in young women.


Asunto(s)
Antioxidantes/farmacología , Ketamina/efectos adversos , Ketamina/antagonistas & inhibidores , Ovario/efectos de los fármacos , Sulfonamidas/farmacología , Útero/efectos de los fármacos , Animales , Femenino , Glutatión/metabolismo , Malondialdehído/metabolismo , Ovario/enzimología , Ovario/metabolismo , Estrés Oxidativo/efectos de los fármacos , Peroxidasa/metabolismo , Distribución Aleatoria , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo , Útero/enzimología , Útero/metabolismo
12.
Biol Reprod ; 101(2): 306-317, 2019 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-31201420

RESUMEN

Enhancer of zeste homolog 2 (EZH2) is a rate-limiting catalytic subunit of a histone methyltransferase, polycomb repressive complex, which silences gene activity through the repressive histone mark H3K27me3. EZH2 is critical for epigenetic effects of early estrogen treatment, and may be involved in uterine development and pathologies. We investigated EZH2 expression, regulation, and its role in uterine development/function. Uterine epithelial EZH2 expression was associated with proliferation and was high neonatally then declined by weaning. Pre-weaning uterine EZH2 expression was comparable in wild-type and estrogen receptor 1 knockout mice, showing neonatal EZH2 expression is ESR1 independent. Epithelial EZH2 was upregulated by 17ß-estradiol (E2) and inhibited by progesterone in adult uteri from ovariectomized mice. To investigate the uterine role of EZH2, we developed a EZH2 conditional knockout (Ezh2cKO) mouse using a cre recombinase driven by the progesterone receptor (Pgr) promoter that produced Ezh2cKO mice lacking EZH2 in Pgr-expressing tissues (e.g. uterus, mammary glands). In Ezh2cKO uteri, EZH2 was deleted neonatally. These uteri had reduced H3K27me3, were larger than WT, and showed adult cystic endometrial hyperplasia. Ovary-independent uterine epithelial proliferation and increased numbers of highly proliferative uterine glands were seen in adult Ezh2cKO mice. Female Ezh2cKO mice were initially subfertile, and then became infertile by 9 months. Mammary gland development in Ezh2cKO mice was inhibited. In summary, uterine EZH2 expression is developmentally and hormonally regulated, and its loss causes aberrant uterine epithelial proliferation, uterine hypertrophy, and cystic endometrial hyperplasia, indicating a critical role in uterine development and function.


Asunto(s)
Proteína Potenciadora del Homólogo Zeste 2/metabolismo , Regulación del Desarrollo de la Expresión Génica/fisiología , Regulación Enzimológica de la Expresión Génica/fisiología , Útero/enzimología , Útero/crecimiento & desarrollo , Animales , Proteína Potenciadora del Homólogo Zeste 2/genética , Células Epiteliales/metabolismo , Receptor alfa de Estrógeno/genética , Receptor alfa de Estrógeno/metabolismo , Estrógenos/metabolismo , Femenino , Histonas/metabolismo , Glándulas Mamarias Animales/enzimología , Glándulas Mamarias Animales/crecimiento & desarrollo , Glándulas Mamarias Animales/metabolismo , Ratones , Ratones Noqueados , Embarazo , Progesterona/metabolismo
13.
Methods Mol Biol ; 2007: 19-36, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31148104

RESUMEN

With potent vasodilatory and pro-angiogenic properties, hydrogen sulfide (H2S) is now accepted as the third gasotransmitter after nitric oxide (NO) and carbon monoxide. Endogenous H2S is mainly synthesized by cystathionine ß-synthase (CBS) and cystathionine γ-lyase (CSE). Akin to previous studies showing hormonal regulation of NO biosynthesis, we first reported that uterine and systemic artery H2S biosynthesis is regulated by exogenous estrogens in an ovariectomized sheep model of estrogen replacement therapy, specifically stimulating CBS, but not CSE, expression, in uterine (UA) and mesenteric (MA), but not carotid (CA), arteries in ovariectomized nonpregnant sheep. We have found significantly elevated H2S biosynthesis due to CBS upregulation under estrogen-dominant physiological states, the proliferative phase of menstrual cycle and pregnancy in primary human UAs. Our studies have pioneered the role of H2S biology in uterine hemodynamics regulation although there is still much that needs to be learned before a thorough elucidation of a role that H2S plays in normal physiology of uterine hemodynamics and its dysregulation under pregnancy complications can be determined. In this chapter we describe a series of methods that we have optimized for analyzing vascular H2S biosynthesis, including (1) real-time quantitative PCR (qPCR) for assessing tissue and cellular levels of CBS and CSE mRNAs, (2) immunoblotting for assessing CBS and CSE proteins, (3) semiquantitative immunofluorescence microscopy to specifically localize CBS and CSE proteins on vascular wall and to quantify their cellular expression levels, and (4) methylene blue assay for assessing H2S production in the presence of selective CBS and CSE inhibitors.


Asunto(s)
Arterias Carótidas/enzimología , Cistationina betasintasa/biosíntesis , Cistationina gamma-Liasa/biosíntesis , Regulación Enzimológica de la Expresión Génica , Sulfuro de Hidrógeno/metabolismo , Complicaciones del Embarazo/enzimología , Animales , Western Blotting/métodos , Arterias Carótidas/patología , Femenino , Humanos , Microscopía Fluorescente/métodos , Embarazo , Complicaciones del Embarazo/patología , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Ovinos , Útero/enzimología , Útero/patología
14.
Reprod Sci ; 26(7): 988-996, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-30428777

RESUMEN

BACKGROUND: Preterm birth is the most common cause of neonatal morbidity and mortality and a common precedent to lifelong disability. Current treatment has minimal efficacy. OBJECTIVE: We assessed the role of isozymes of the protein kinase C (PKC) family in regulating the phosphorylation of myosin regulatory light chains (RLCs), which regulate uterine contractility. We also explored the mechanisms through which these isozymes function. STUDY DESIGN: We used a previously characterized and validated quantitative in-cell Western (ICW) assay to measure site-specific phosphorylations on myosin RLC and CPI-17. Cultures of human uterine myocytes (hUM) were treated with the potent contractile stimulant oxytocin to induce uterine contractility or a pharmacological mimic of diacyl-glycerol to stimulate the conventional and novel isozymes of the PKC family. Combinations of isozyme-selective inhibitors were used to determine the effects of the conventional and novel classes of isozymes. RESULTS: Stimulation of PKC using phospho-dibutyrate caused immediate, concentration-dependent inhibition of uterine activity ex vivo. Using the ICW assay with hUM, the oxytocin-stimulated increase in the pro-contractile phosphorylations of myosin RLCs at serine19 and threonine18 was completely inhibited by prior treatment with phorbol-12-myristate-13-acetate, which stimulates both convention and novel classes of isozymes. Our results suggest that the conventional class of isozymes cause a reduction in phosphorylations at serine19 and threonine18 by reducing activity of myosin light chain kinase. The novel class of isozymes has 2 mechanisms of action: the first is activation of CPI-17 through phosphorylation at threonine38, which results in reduced activity of myosin light chain phosphatase and increased levels of activated myosin RLC; the second is increased phosphorylation of the N-terminal region of myosin RLC. CONCLUSIONS: Specific agonists for the conventional isozymes or inhibitors of the novel isozymes of the PKC family could be useful pharmacological agents for regulation of uterine activity.


Asunto(s)
Miocitos del Músculo Liso/enzimología , Cadenas Ligeras de Miosina/metabolismo , Proteína Quinasa C/metabolismo , Contracción Uterina , Útero/enzimología , Animales , Células Cultivadas , Activación Enzimática , Activadores de Enzimas/farmacología , Femenino , Humanos , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Isoenzimas , Proteínas Musculares/metabolismo , Miocitos del Músculo Liso/efectos de los fármacos , Quinasa de Cadena Ligera de Miosina/metabolismo , Oxitócicos/farmacología , Fosforilación , Proteína Quinasa C/antagonistas & inhibidores , Inhibidores de Proteínas Quinasas/farmacología , Ratas Sprague-Dawley , Transducción de Señal , Contracción Uterina/efectos de los fármacos , Útero/citología , Útero/efectos de los fármacos
15.
Endocrinology ; 160(1): 235-248, 2019 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-30476019

RESUMEN

Class II phosphoinositide 3-kinases (PI3Ks), PI3K-C2α and PI3K-C2ß, are highly homologous and distinct from class I and class III PI3Ks in catalytic products and domain structures. In contrast to class I and class III PI3Ks, physiological roles of PI3K-C2α and PI3K-C2ß are not fully understood. Because we previously demonstrated that PI3K-C2α is involved in vascular smooth muscle contraction, we studied the phenotypes of smooth muscle-specific knockout (KO) mice of PI3K-C2α and PI3K-C2ß. The pup numbers born from single PI3K-C2α-KO and single PI3K-C2ß-KO mothers were similar to those of control mothers, but those from double KO (DKO) mothers were smaller compared with control mice. However, the number of intrauterine fetuses in pregnant DKO mothers was similar to that in control mice. Both spontaneous and oxytocin-induced contraction of isolated uterine smooth muscle (USM) strips was diminished in DKO mice but not in either of the single KO mice, compared with control mice. Furthermore, contraction of USM of DKO mice was less sensitive to a Rho kinase inhibitor. Mechanistically, the extent of oxytocin-induced myosin light chain phosphorylation was greatly reduced in USM from DKO mice compared with control mice. The oxytocin-induced rise in the intracellular Ca2+ concentration in USM was similar in DKO and control mice. However, Rho activation in the intracellular compartment was substantially attenuated in DKO mice compared with control mice, as evaluated by fluorescence resonance energy transfer imaging technique. These data indicate that both PI3K-C2α and PI3K-C2ß are required for normal USM contraction and parturition mainly through their involvement in Rho activation.


Asunto(s)
Fosfatidilinositol 3-Quinasas Clase II/metabolismo , Músculo Liso Vascular/enzimología , Parto , Fosfatidilinositol 3-Quinasas/metabolismo , Contracción Uterina , Útero/enzimología , Proteína de Unión al GTP rhoA/metabolismo , Animales , Fosfatidilinositol 3-Quinasas Clase II/genética , Femenino , Ratones , Ratones Noqueados , Contracción Muscular , Músculo Liso Vascular/fisiología , Cadenas Ligeras de Miosina , Fosfatidilinositol 3-Quinasas/genética , Fosforilación , Útero/fisiología , Proteína de Unión al GTP rhoA/genética
16.
FEBS Lett ; 592(22): 3696-3707, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30220088

RESUMEN

The receptive uterine endometrium specifically expresses certain glycosyltransferases, and the corresponding oligosaccharides play important roles in accepting the embryo. The sialyltransferase ß-galactoside-α2,3-sialyltransferase III (ST3Gal3) is the key enzyme responsible for sialyl Lewis X (sLeX) oligosaccharide biosynthesis, but the expression and function of ST3Gal3 in the receptive endometrium is still elusive. Here, we found that human endometrial tissues at secretory phase expressed a 4-fold higher ST3Gal3 level relative to the tissues at proliferative phase. Meanwhile, downregulation of ST3Gal3 or sLeX epitope blockage significantly impaired the receptive ability of human endometrial RL95-2 cells to trophoblastic cells in vitro and inhibited implantation in pregnant mice. This study suggests that ST3Gal3 facilitates endometrial receptivity through increasing sLeX oligosaccharide, which gives a better understanding of the glycobiology of implantation.


Asunto(s)
Endometrio/metabolismo , Expresión Génica , Sialiltransferasas/genética , Útero/metabolismo , Animales , Línea Celular Tumoral , Proliferación Celular/genética , Implantación del Embrión , Endometrio/enzimología , Femenino , Humanos , Ratones , Oligosacáridos/metabolismo , Embarazo , Interferencia de ARN , Antígeno Sialil Lewis X , Sialiltransferasas/metabolismo , Útero/enzimología
17.
Reprod Domest Anim ; 53(3): 769-775, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29542183

RESUMEN

The objective of this study was to consider endocannabinoid system as inflammatory markers in bovine endometrium to better understand the role of this system in regulating many of the functions that are related to inflammatory condition. At day 26 post-partum, fourteen cows were divided into two groups depending on the inflammatory condition: 1- subclinical endometritis (n = 7, with purulent or mucopurulent uterine discharge detectable in the vagina) and 2- healthy (n = 7, No (muco)) purulent discharge. Blood samples were collected at 26 and 30 days relative to calving to determine plasma tumour necrosis factor (TNF) and lipopolysaccharide-binding protein (LBP) concentrations; moreover, uterine biopsy was carried out on day 26 post-partum to measure mRNA abundance of TNF, interleukin-1B (IL1B), interleukin-6 (IL-6), C-X-C motif chemokine ligand 8 (CXCL8), endocannabinoid receptor (CNR2), N-acyl phosphatidylethanolamine phospholipase D (NAPEPLD), fatty acid amide hydrolase (FAAH), N-acylethanolamine acid amidase (NAAA) and monoglyceride lipase (MGLL) by real-time PCR. Results showed mean plasma concentrations of TNF and LBP were lower in healthy cows compared to subclinical endometritis cows (p < .05). Relative mRNA expression for NAAA and FAAH was decreased (p < .05), and relative mRNA expression for CNR2 and NAPEPLD increased in cows with subclinical endometritis compared to healthy cows. In conclusion, relative mRNA expression of TNF, IL1B and CXCL8 and plasma concentration of LBP increased during inflammatory condition along with decreased endocannabinoids hydrolyzing enzyme (NAAA and FAAH), increased enzymes that synthesize endocannabinoids (NAPEPLD) and relative gene expression of the endocannabinoid receptor; together, these contribute to increased endocannabinoids levels during inflammation. Overall, we provide evidence that endocannabinoid system is altered in endometrium tissue during inflammation through increased mRNA expression of CNR2 and synthesis enzyme and decreased mRNA expression of hydrolyzing enzymes interfere with pro-cytokine production and signalling, which may interfere with the onset and progression of inflammation.


Asunto(s)
Enfermedades de los Bovinos/patología , Citocinas/metabolismo , Endocannabinoides/metabolismo , Endometritis/patología , Proteínas de Fase Aguda/análisis , Animales , Proteínas Portadoras/sangre , Bovinos , Enfermedades de los Bovinos/metabolismo , Endocannabinoides/genética , Endometritis/metabolismo , Femenino , Expresión Génica , Lactancia , ARN Mensajero/metabolismo , Receptores de Cannabinoides/análisis , Factor de Necrosis Tumoral alfa/sangre , Útero/enzimología , Útero/metabolismo
18.
Biomed Pharmacother ; 102: 517-530, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29587238

RESUMEN

Cisplatin (CP) is a widely used chemotherapeutic drug, effective against a variety of solid tumours, though its utility is limited due to its multiple organ toxicity. Zingerone (ZO), one of the most important components of dry ginger root, has several pharmacological activities, such as antioxidant, anti-inflammatory and anti-apoptotic properties. This study aimed to investigate the ameliorative effect of ZO on CP-induced ovarian and uterine toxicity in female rats. The rats were subjected to a prophylactic oral treatment of ZO (25 and 50 mg/kg body weight) for seven days to measure the protective effect against ovarian and uterine toxicity induced by a single (i.p.) of CP (7 mg/kg body weight) on the first day whereas the rats were sacrificed on the eighth day. The results showed that ZO decreased the serum FSH hormone level, increased the serum E2 hormone level, and also maintained the ovarian and uterine histological architecture and integrity. In addition, ZO obviously increased the measured activity of antioxidant enzymes (SOD, CAT and GPx) and the GSH content, and significantly reduced MDA levels. ZO was able to reduce the levels of the inflammatory markers NF-κB, TNF-α, IL-1ß, IL-6, COX-2 and iNOS in CP-induced ovarian and uterine damage. It also inhibited apoptosis and reduced oxidative DNA damage markers by the downregulation of caspase-3 and 8-OHdG expression coupled with an upregulated Bcl-2 level. The results indicate that ZO may be beneficial in ameliorating CP-induced oxidative stress, sex hormone imbalances, inflammation and apoptosis in ovarian and uterine tissues of female rats.


Asunto(s)
Apoptosis , Cisplatino/efectos adversos , Hormonas Esteroides Gonadales/metabolismo , Guayacol/análogos & derivados , Inflamación/patología , Ovario/patología , Estrés Oxidativo , Útero/patología , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Antioxidantes/metabolismo , Apoptosis/efectos de los fármacos , Caspasa 3/metabolismo , Catalasa/metabolismo , Ciclooxigenasa 2/metabolismo , Desoxiguanosina/análogos & derivados , Desoxiguanosina/metabolismo , Estradiol/sangre , Femenino , Hormona Folículo Estimulante/sangre , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Guayacol/farmacología , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Malondialdehído/metabolismo , FN-kappa B/metabolismo , Ovario/efectos de los fármacos , Ovario/enzimología , Estrés Oxidativo/efectos de los fármacos , Ratas Wistar , Superóxido Dismutasa/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Útero/efectos de los fármacos , Útero/enzimología
19.
Bull Exp Biol Med ; 164(3): 386-389, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29308563

RESUMEN

A comparative immunohistochemical study for the expression of O6-methylguanine-DNA methyltransferase (MGMT) was performed in tissues of the eutopic endometrium and ovarian endometriosis. The highest level of MGMT expression in eutopic endometrial tissue was observed in epitheliocyte nuclei during the proliferative phase. In regions of endometriosis the expression of MGMT in epitheliocyte nuclei was shown to increase during stages I and II, but decreased in stages III and IV. The progression of endometriosis was accompanied by a gradual increase of study parameters in the nuclei and cytoplasm of stromal cells. These changes reflect the impairment of DNA reparation, which probably serves as a stage in the development and progression of endometriosis.


Asunto(s)
Metilasas de Modificación del ADN/genética , Enzimas Reparadoras del ADN/genética , Reparación del ADN , Endometriosis/genética , Ovario/enzimología , Células del Estroma/enzimología , Proteínas Supresoras de Tumor/genética , Adolescente , Adulto , ADN/genética , ADN/metabolismo , Metilasas de Modificación del ADN/metabolismo , Enzimas Reparadoras del ADN/metabolismo , Progresión de la Enfermedad , Endometriosis/enzimología , Endometriosis/patología , Células Epiteliales/enzimología , Células Epiteliales/patología , Femenino , Regulación de la Expresión Génica , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Ovario/patología , Células del Estroma/patología , Proteínas Supresoras de Tumor/metabolismo , Útero/enzimología , Útero/patología
20.
Life Sci ; 192: 199-204, 2018 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-29196050

RESUMEN

AIMS: Lipid soluble vitamin E plays a role in several physiological mechanisms, however, the mechanism of this action is controversial. We investigated how tocopherol (α-tocopherol acid succinate) influences the effects of cyclooxygenase inhibitors (COXi) in the smooth muscles. MAIN METHODS: The contractility of the samples from 22-day-pregnant myometrium and non-pregnant myometrium and trachea was determined in an isolated organ bath in vitro. The activity of cyclooxygenase enzymes (COX) was also measured in the tissues. KEY FINDINGS: Diclofenac (10-9-10-5M) and rofecoxib (10-10-10-5M) decreased the contractions in non-pregnant and 22-day-pregnant uteri. Tocopherol (10-7M) increased the relaxant effect only in pregnant uteri. Both diclofenac (10-9-10-5M) and rofecoxib (10-10-10-5M) reduced the tracheal tones, while they were slightly intensified by pretreatment with tocopherol (10-7M). Tocopherol enhanced the contractions of pregnant uteri. Tocopherol (10-7M) itself can induce the cyclooxygenase activity and shift the COX-1 and COX-2 ratio to COX-2. The lowest COX activity was found in non-pregnant uteri, while the highest one was in the trachea. SIGNIFICANCE: The COX enzymes, especially COX-2, play an important role in the contraction of pregnant uteri in rat. Tocopherol has a tissue specific COX-2 activity increasing effect in pregnant rat uterus but has no such action in non-pregnant uteri or tracheal tissue. Hereby, tocopherol may intensify selectively the uterine relaxing effect of COX-2 inhibitors in preterm contractions. However, tocopherol can enhance the contractile response of pregnant uterus that may increase the risk of premature contractions.


Asunto(s)
Ciclooxigenasa 2/biosíntesis , Útero/enzimología , alfa-Tocoferol/farmacología , Animales , Ciclooxigenasa 1/metabolismo , Inhibidores de la Ciclooxigenasa 2/farmacología , Femenino , Técnicas In Vitro , Proteínas de la Membrana/metabolismo , Músculo Liso/efectos de los fármacos , Miometrio/efectos de los fármacos , Miometrio/enzimología , Miometrio/metabolismo , Especificidad de Órganos , Embarazo , Ratas , Ratas Sprague-Dawley , Tráquea/enzimología , Contracción Uterina/efectos de los fármacos , Útero/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA